Vazegepant
| CAS No. | 1337918-83-8 | Cat. No. | BCP46647 |
| Name | Vazegepant | ||
| Synonyms | Zavegepant; BMS 742413; BMS-742413; BMS742413; BHV-3500; BHV 3500; BHV3500; | ||
| Formula | C36H46N8O3 | M. Wt | 638.8 |
| Description | Vazegepant is an antagonist of the calcitonin gene-related peptide (CGRP) receptor currently in phase 3 trials in an intranasal formulation for the treatment of migraine. If FDA approved, it will join other previously-approved "-gepant" drugs [rimegepant] and [ubrogepant] as an additional treatment alternative for patients with migraine, particularly those for whom traditional triptan therapy has proven ineffective. | ||
| Related Products | 1414976-20-7（Vazegepant hydrochloride） | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | CGRP Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.